Last Update: Nov 09, 2026
A Double-blind, Double-dummy, Parallel Group, Multicenter Phase 3 Extension Study Evaluating the Long-term Safety and Efficacy of 2 Doses of Remibrutinib in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
ClinicalTrials.gov Identifier:
Novartis Reference Number:CLOU064J12303B
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.

Study Description

The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of remibrutinib (LOU064) in adult participants with moderate to severe hidradenitis suppurativa (HS) who have completed either of the preceding Phase 3 studies, CLOU064J12301 or CLOU064J12302. This is a global Phase 3, multicentre, double-blind, double-dummy, parallel-group extension study. It fulfils the Novartis commitment to provide post-trial access.

The study includes a double-blind and an open-label treatment phase:

Double-blind, double-dummy treatment continues from Week 68 (end of core study) until final database lock (DBL) of both core studies or until up titration. Participants remain on the same blinded regimen they were on during Treatment Period 2 of the preceding Phase 3 studies.

After final DBL of both core studies, treatment transitions to open-label.

Participants will continue treatment until commercial availability and reimbursement in their country, another access mechanism is available, or 4 years of extension treatment is completed.

Participants who discontinue treatment early or do not transition to commercial remibrutinib will enter a 4-week treatment-free safety follow-up.

Hidradenitis Suppurativa
Phase3
Recruiting
710
Jul 10, 2026
Oct 15, 2031
All
18 Years - 100 Years (Adult, Older Adult)

Interventions

Drug

Remibrutinib

Remibrutinib Dose A and B (oral)

Eligibility Criteria

Key Inclusion Criteria:

* Signed informed consent must be obtained before any assessment is performed.
* Participant has completed the full study treatment period according to the protocol (68 weeks) in the core studies (CLOU064J12301 or CLOU064J12302).
* Participant does not meet any treatment discontinuation criteria of the core study at Week 68.

Key Exclusion Criteria:

* Ongoing or planned use of prohibited HS or non-HS treatments.
* Participants not expected to benefit from participation in the extension study or participants expected to be exposed to an undue safety risk if participating in the extension study, as assessed by the Investigator.
* Current severe progressive or uncontrolled disease, which in the judgment of the Investigator renders the participant unsuitable for the study.

Other protocol-defined inclusion/exclusion criteria may apply.

Novartis Investigative Site

Recruiting

CABA,C1428dzf,Argentina

Novartis Investigative Site

Recruiting

Caba,Buenos Aires,C1119acn,Argentina

Novartis Investigative Site

Recruiting

CABA,C1012aay,Argentina

Novartis Investigative Site

Recruiting

CABA,Buenos Aires,C1425bea,Argentina

Novartis Investigative Site

Recruiting

Rosario,Santa Fe Province,S2000dbs,Argentina

Novartis Investigative Site

Recruiting

Sydney,New South Wales,2010,Australia

Novartis Investigative Site

Recruiting

Melbourne,Victoria,3004,Australia

Novartis Investigative Site

Recruiting

Parkville,Victoria,3050,Australia

Novartis Investigative Site

Recruiting

Edmonton,Alberta,T6g 1c3,Canada

Novartis Investigative Site

Recruiting

Québec,Quebec,G1v 4t3,Canada

Novartis Investigative Site

Recruiting

Montreal,Quebec,H1y 3l1,Canada

Novartis Investigative Site

Recruiting

London,Ontario,N6h 5l5,Canada

Novartis Investigative Site

Recruiting

Beijing,100144,China

Novartis Investigative Site

Recruiting

Prague,180 81,Czechia

Novartis Investigative Site

Recruiting

Reims,51100,France

Novartis Investigative Site

Recruiting

Lyon,69003,France

Novartis Investigative Site

Recruiting

Rouen,76031,France

Novartis Investigative Site

Recruiting

Darmstadt,Hesse,64283,Germany

Novartis Investigative Site

Recruiting

Würzburg,Bavaria,97080,Germany

Novartis Investigative Site

Recruiting

Freiburg im Breisgau,Baden-Wurttemberg,79106,Germany

Novartis Investigative Site

Recruiting

Düsseldorf,North Rhine-Westphalia,40225,Germany

Novartis Investigative Site

Recruiting

Minden,32429,Germany

Novartis Investigative Site

Recruiting

Bochum,44791,Germany

Novartis Investigative Site

Recruiting

Ancona,AN,60020,Italy

Novartis Investigative Site

Recruiting

George Town,Pulau Pinang,10450,Malaysia

Novartis Investigative Site

Recruiting

Muar town,Johor,84000,Malaysia

Novartis Investigative Site

Recruiting

Selangor Darul Ehsan,68100,Malaysia

Novartis Investigative Site

Recruiting

Kota Kinabalu,Sabah,88586,Malaysia

Novartis Investigative Site

Recruiting

Ipoh,Perak,30450,Malaysia

Novartis Investigative Site

Recruiting

Kuala Lumpur,Kuala Lumpur,50586,Malaysia

Novartis Investigative Site

Recruiting

Warsaw,Masovian Voivodeship,02-953,Poland

Novartis Investigative Site

Recruiting

Las Palmas GC,35010,Spain

Novartis Investigative Site

Recruiting

Madrid,28041,Spain

Novartis Investigative Site

Recruiting

Barcelona,Catalonia,08003,Spain

RFSA Dermatology

Recruiting

San Antonio,Texas,78213,United States

Lindsey Finklea
Jonathan Joseph

Cameron Dermatology

Recruiting

New York,New York,10023,United States

Michael Cameron
Yamiles Gonzalez

Skin Specialists PC

Recruiting

Omaha,Nebraska,68144,United States

Kayleigh Koziol
Joel Schlessinger

University of MiamiHealth System

Recruiting

Miami,Florida,33125,United States

Aliette Espinosa
Hadar Lev-Tov

Revival Research Institute

Recruiting

Troy,Michigan,48084,United States

Ali Moiin
Jill Solanki

Skinsearch of Rochester Inc

Recruiting

Rochester,New York,14623,United States

Angela Malizia
John H Tu

Medical University of South Carolina MUSC

Recruiting

Charleston,South Carolina,29425,United States

Lara Wine Lee
Madeline Richmond

Optima Research Boardman

Recruiting

Boardman,Ohio,44512,United States

Patrick Shannon
Sarah Merlo

Forefront Dermatology

Recruiting

Vienna,Virginia,22182,United States

Jacqueline Henley
Sarah Taylor

Dundee Dermatology

Recruiting

West Dundee,Illinois,60118,United States

Paul Getz
JoAnn Hawkinson

Olive View UCLA Medical Center

Recruiting

Sylmar,California,91342,United States

Noel Yang
April Armstrong

USC Keck School of Medicine

Recruiting

Los Angeles,California,90033,United States

Rudy Rocha
Katrina Lee

Endeavor Health

Recruiting

Glenview,Illinois,60077,United States

Megan Calderon
Shannon Ewing

Southern IN Clinical Trials

Recruiting

New Albany,Indiana,47150,United States

Misty Humphress
Megan Landis

Ctr for Dermatology Clinical Res

Recruiting

Fremont,California,95438,United States

Evguenia Vals
Sunil Dhawan

Clinical Trials Research Institute

Recruiting

Thousand Oaks,California,91320,United States

Navid Ezra
Joanna Vargas

Floridian Research Institute

Recruiting

Miami,Florida,33179,United States

Faride Ramos
Luis Javier Arechavaleta

University Of South Florida

Recruiting

Tampa,Florida,33612,United States

Ann Lin
Zachary Leniek

Icahn School Of Med At Mount Sinai

Recruiting

New York,New York,10029,United States

Jillian Gray
Nadine Kaskas

OnSite Clinical Solutions LLC

Recruiting

Huntersville,North Carolina,28078,United States

April Page
Nicole Seminara-Zambrzycka

Center for Clinical Studies-Lee

Recruiting

Webster,Texas,77598,United States

Karina Gonzalez
Patricia C Lee

Johnson Dermatology

Recruiting

Fort Smith,Arkansas,72916,United States

Sandra Johnson
Christa Elliott

Clinical Research Ctr of Carolinas

Recruiting

Charleston,South Carolina,29407,United States

Gina Gregory
Todd Schlesinger

Apex Clinical Research Center LLC

Recruiting

Mayfield Heights,Ohio,44124,United States

Stacey Spigiel
Jorge Garcia-Zuazaga

Total Skin and Beauty Dermatology Center PC

Recruiting

Birmingham,Alabama,35205,United States

Brittany Powell
Rajini Murthy

Arkansas Research Trials

Recruiting

North Little Rock,Arkansas,72117,United States

Scott Michael Dinehart
Shawna Owens

UP Medical Center H System

Recruiting

Pittsburgh,Pennsylvania,15213-3403,United States

Carisa Byich
Joe Kuanheng Tung

Worldwide Contacts

If the location of your choosing does not feature any contact detail, please reach out using the information below.

Novartis Pharmaceuticals

Novartis Pharmaceuticals